The fact
These nanomedicines activate only in the presence of tumor markers, limiting side effects.
This approach opens a new therapeutic pathway for cancers resistant to conventional treatments.
Click the link to read an article on the topic:
These nanomedicines activate only in the presence of tumor markers, limiting side effects.
This approach opens a new therapeutic pathway for cancers resistant to conventional treatments.